Results of a 50% interim analysis showed 25% of those continuing medication experienced clinically significant RGV, whereas only 3.1% of those holding medication experienced the same (absolute difference, 21.9%
For patients who plateau, switching medications can reignite progress
This streamlined model benefits both uninsured patients and those whose insurance excludes weight-loss medications
The DIAL model was considered for use in our analysis, as it was developed with data from patients both with and without established CVD (19% and 81%, respectively) [51]
For best results, take before or after any physicalactivity
Both medications commonly cause gastrointestinal side effects like nausea, especially when starting treatment